A study of aspects on gender and prognosis in synchronous colorectal cancer

Clinical Medicine Insights: Oncology

Volumn 5, Issue , 2011, Pages 259-264

  Derwinger, Kristoffer ^a   Gustavsson, Bengt ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Colorectal cancer; Gender; Mortality; Multiple tumors; Survival

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CLINICAL ASSESSMENT; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LYMPHATIC SYSTEM EXAMINATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; OVERALL SURVIVAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; SEX DIFFERENCE; TUMOR DIFFERENTIATION;

EID: 80053590640     PISSN: 11795549     EISSN: 11795549     Source Type: Journal    
DOI: 10.4137/CMO.S7871     Document Type: Article

References (27)

1. Socialstyrelsen. Cancer incidence in Sweden 1999. 2001. 2001, Swedish National Board of Health, Stockholm.
2. Welch JP. Multiple colorectal tumors. An appraisal of natural history and therapeutic options. Am J Surg. 1981;142(2):274-80.
3. Fante R, Roncucci L, Di Gregorio C, et al. Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma. Cancer. 1996;77(10):2013-21.
4. Kehoe J and Khatri VP. Staging and prognosis of colon cancer. Surg Oncol Clin N Am. 2006;15(1):129-46.
5. Cunliffe WJ, Hasleton PS, Tweedle DE, Schofield PF. Incidence of synchronous and metachronous colorectal carcinoma. Br J Surg. 1984;71(12): 941-3.
6. Box JC, Rodriguez-Bigas MA, Weber TK, Petrelli NJ. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum. 1999;42(6):717-21.
7. Pinol V, Andreu M, Castells A, Paya A, Bessa X, Jover R. Synchronous colorectal neoplasms in patients with colorectal cancer: predisposing individual and familial factors. Dis Colon Rectum. 2004;47(7):1192-200.
8. Oya M, Takahashi S, Okuyama T, Yamaguchi M, Ueda Y. Synchronous colorectal carcinoma: clinico-pathological features and prognosis. Jpn J Clin Oncol. 2003;33(1):38-43.
9. Luchtefeld MA, Ross DS, Zander JD, Folse JR. Late development of metachronous colorectal cancer. Dis Colon Rectum. 1987;30(3):180-4.
10. McFall MR, Woods WG, Miles WF. Colonoscopic surveillance after curative colorectal resection: results of an empirical surveillance programme. Colorectal Dis. 2003;5(3):233-40.
11. Passman MA, Pommier RF, Vetto JT. Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum. 1996; 39(3):329-4.
12. Chen HS, Sheen-Chen SM. Synchronous and "early" metachronous colorectal adenocarcinoma: analysis of prognosis and current trends. Dis Colon Rectum. 2000;43(8):1093-9.
13. Adloff M, Arnaud JP, Bergamaschi R, Schloegel M. Synchronous carcinoma of the colon and rectum: prognostic and therapeutic implications. Am J Surg. 1989;157(3):299-302.
14. McArdle CS, McMillan DC, Hole DJ. Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg. 2003;90(6):711-5.
15. Wichmann MW, Muller C, Hornung HM, Lau-Werner U, Schildberg FW. Gender differences in long-term survival of patients with colorectal cancer. Br J Surg. 2001;88(8):1092-8.
16. UICC/AJCC. TNM Classification of Malignant Tumors, fifth edition (1997). Wiley-Liss, NY, 1997.
17. Devitt JE, Roth-Moyo LA, Brown FN. The significance of multiple adenocarcinomas of the colon and rectum. Ann Surg. 1969;169(3):364-7.
18. Rennert G, Robinson E, Rennert HS, Neugut AI. Clinical characteristics of metachronous colorectal tumors. Int J Cancer. 1995;60(6):743-7.
19. Enker WE, Dragacevic S. Multiple carcinomas of the large bowel: a natural experiment in etiology and pathogenesis. Ann Surg. 1978;187(1):8-11.
20. Wang HZ, Huang XF, Wang Y, Ji JF, Gu J. Clinical features, diagnosis, treatment and prognosis of multiple primary colorectal carcinoma. World J Gastroenterol. 2004;10(14):2136-9.
21. Jass JR. Colorectal cancer. a multipathway disease. Crit Rev Oncog. 2006; 12(3-4):273-87.
22. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50(1):113-30.
23. Masubuchi S, Konishi F, Togashi K, et al. The significance of microsatellite instability in predicting the development of metachronous multiple colorectal carcinomas in patients with nonfamilial colorectal carcinoma. Cancer. 1999;85(9):1917-24.
24. Pedroni M, Tamassia MG, Percesepe A, et al. Microsatellite instability in multiple colorectal tumors. Int J Cancer. 1999;81(1):1-5.
25. Ueda E, Watanabe T, Umetani N, Ishigami H, Sasaki S, Nagawa H. Microsatellite instability of cancers and concomitant adenomas in synchronous multiple colorectal cancer patients. J Exp Clin Cancer Res. 2002;21(2): 149-54.
26. Odin E, Wettergren Y, Nilsson S, et al. Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. Clin Cancer Res. 2003;9(16 Pt 1):6012-9.
27. Wettergren Y, Odin E, Nilsson S, Carlsson G, Gustavsson B. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer. Mol Med. 2008;14(7-8):412-21.